Symptoms include:

1.  Headache, usually throbbing, bitemporal or occipital, typically worse at  night, upon awakening, and made worse by Valsalva manuever, or stooping over. This is the most common and prominent sign.

2.  Fatigue

3.  Dizziness

4.  Anorexia

5.  Respiratory difficulties

     a. Dyspnea on exertion (DOE)

     b. Cheyne-Stokes breathing

               6.  Nausea

               7.  Vomiting

               8.  Warm and flushed feeling of the face

               9.  Insomnia

             10.  Palpatations and vague pains in the posterolateral chest

 11.  Decreased capacity for mental work

            12.  Tinnitus

            13.  Memory defects

            14.  Vertigo

15.  Ataxia may occur and it may be progressive. 

       (The presence of ataxia is ominous and this is a clear indication for     

        descent). 

NOTE:  AMS is commonly misdiagnosed as a viral flu-like illness, exhaustion, or dehydration.

3.  Field Management:

a.  Descend.  The individual should descend 1,000-3,000 feet, at which point 

     the patient should have marked relief of symptoms.

b.  Overexertion: Avoid overexertion.  Light duty.

c.  Fluids  Adequate: Fluid replacement and a light diet.

d.  Pain Relievers: Mild analgesics such as Aspirin, Tylenol, or Motrin to treat the  

     headache.

e.  Hyperventilation.  The victim can also hyperventilate for about one minute

     every 10-15 minutes while awake.

f.  ALL PATIENTS WITH AMS SHOULD BE EVALUATED FOR HIGH    

    ALTITUDE PULMONARY EDEMA (HAPE).

g.  Do not allow the patient to use any tobacco products.

NOTE: Dizziness/numbness.  Care must be taken not to hyperventilate to the point of getting dizzy or developing numbness and tingling fingers, toes, lips.

4.  Prevention Measures: 

a.  The key and best approach is:

1.  Staged ascent no higher than 8,000 feet the first day.

2.  Spend the next 24 hours resting.

3.  Continue the ascent at about 1,000 feet altitude gain per day.

4.  Avoid overexertion and tobacco use.

5.  Maintain adequate fluid intake.

6.  Use the “work high/sleep low” concept.  This is called "Graded Ascent"    

     which is the surest and safest way to prevent AMS.  Day trips to higher

     altitude and sleeping at lower altitude allows for a slower ascent but allows

     for the body to adjust to altitude better.

B.  HIGH ALTITUDE PULMONARY EDEMA (HAPE)

     1.  Definition:  HAPE is a high altitude illness which is characterized by filling of the 

          lungs with fluid. 

a.  HAPE rarely occurs below 8,000 feet and usually occurs above 12,000 feet.

b.  Persons with history of previous attacks of HAPE are likely to have recurrent

     episodes with subsequent ascents.

c.  HAPE is more common in high altitude residents who return to sea level then

     return to altitude.

d.  Episodes that occur a 8,000 to 10,000 feet usually are related to heavy physical

     exertion.

e.  The incidence of HAPE is 13 times greater in the 20 to 29 year age group than

     the over 30 year age group.

        2.  Signs and Symptoms 

             a.  These tend to occur within 24-48 hours after arrival.  Usually the symptoms       

                   of AMS are present before or occur with the symptoms of HAPE. 

   b.  Early Signs:

        1.  Dry cough, frequently occurring at night.

        2.  Respiratory distress, made worse by exertion.

        3.  Mild chest pain, usually perceived as an ache beneath the sternum.

        4.  Weakness.

             c.  Later Signs:

1.      Cyanosis.

2.      Cough that produces large amounts of frothy, pink sputum.

3.      Rapid pulse and respirations.

4.      Audible gurgling sounds during breathing.  When a stethoscope or

      ear is placed on the naked chest, wet-crackling sounds can be heard

      as the patient breathes.

5.      Severe respiratory distress.

      3.   Field Treatment:

a)  The most important emergency care measure is the immediate descent to a

     lower altitude since fatalities can occur within 6-12 hours in severe cases.

b)  Usually descent of at least 2,000-3,000 feet below the initial altitude is a

      definite treatment and will result in marked improvement.

c)  The patient should be placed in the most comfortable position (usually sitting)

     and given high concentration oxygen if available.

d) Remember that the lungs are the target, support ventilation may be

     necessary when indicated.

e) Treat headaches with mild analgesics such as Tylenol, Motrin, or Aspirin.

f)  Remember HAPE is a MEDICAL EMERGENCY and medevac must be

    URGENT.

      4.   Prevention Measures.  The methods of prevention are identical to

those outlined for AMS.

C.  HIGH ALTITUDE CEREBRAL EDEMA (HACE)

1.  Definition:  HACE is a high altitude illness that is characterized by swelling of the

     brain.

a.  HACE can occur as low as 8,000 feet, but typically occurs at more than 12,000 feet.

b.  The incidence of HACE in persons brought rapidly to high altitudes is

      approximately 2%.

       2.  Mechanism of HACE

            a.  Hypoxia causes cerebral vasodilatation and an increase in cerebral blood

                 volume. 

 3.  Signs and Symptoms: 

      a.  Early signs and symptoms:

                 1.  Headache, which usually is throbbing and may be severe.

                 2.  Nausea, vomiting.

                 3.  Insomnia.

                 4.  Cheyne-Stokes respirations.

b.  Later signs and symptoms:

                 1.  Ataxia (loss of muscle coordination leading to difficulty maintaining

     balance).

                 2.  Confusion, which may progress to stupor, coma and death without proper

     treatment.

                 3.  Paralysis of one or more extremities, which may resemble the paralysis

     seen in stroke.

                 4.  Blindness.

                 5.  Convulsions

c.  Many patients develop retinal hemorrhages, which can be seen with a

      opthalmoscope by suitable trained individuals.  The patient is un-aware of the

      hemorrhages unless they are present in the parts of the retina responsible for

      sharpest vision (macula).

d.  The most important impediment to early recognition is its insidious onset. 

     Early signs and symptoms frequently go unrecognized or are ignored by

     patients and their companions.

3.  Field Treatment:

a.  Treatment should be immediate since fatalities can occur within a few hours in

     severe cases.

b.  Once diagnosed, the patient should be placed in the most comfortable position

     possible, descended immediately and should be administered high concentrations

     of oxygen if available.

c.  Medevac to a medical facility ASAP!

4.  Prevention:

a.  Prevention is the same as discussed for AMS and HAPE.

b.  There is no known pharmacological agent for the prevention of HACE.

REFERENCES (S)

Wilderness Medicine, Management of Wilderness and Environmental Injuries

Field Medical Service School
Camp Pendleton, California

Approved for public release; Distribution is unlimited.

The listing of any non-Federal product in this CD is not an endorsement of the product itself, but simply an acknowledgement of the source. 

Operational Medicine 2001
Health Care in Military Settings

Home  ·  Military Medicine  ·  Sick Call  ·  Basic Exams  ·  Medical Procedures  ·  Lab and X-ray  ·  The Pharmacy  ·  The Library  ·  Equipment  ·  Patient Transport  ·  Medical Force Protection  ·  Operational Safety  ·  Operational Settings  ·  Special Operations  ·  Humanitarian Missions  ·  Instructions/Orders  ·  Other Agencies  ·  Video Gallery  ·  Phone Consultation  ·  Forms  ·  Web Links  ·  Acknowledgements  ·  Help  ·  Feedback

*This web version is provided by The Brookside Associates Medical Education Division.  It contains original contents from the official US Navy NAVMED P-5139, but has been reformatted for web access and includes advertising and links that were not present in the original version. This web version has not been approved by the Department of the Navy or the Department of Defense. The presence of any advertising on these pages does not constitute an endorsement of that product or service by either the US Department of Defense or the Brookside Associates. The Brookside Associates is a private organization, not affiliated with the United States Department of Defense.

Contact Us  ·  ·  Other Brookside Products